These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37045781)

  • 21. Variable presentations of
    Oza CM; Karguppikar MB; Khadilkar V; Khadilkar A
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35228227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy.
    Capuano M; Garcia-Herrero CM; Tinto N; Carluccio C; Capobianco V; Coto I; Cola A; Iafusco D; Franzese A; Zagari A; Navas MA; Sacchetti L
    PLoS One; 2012; 7(6):e38906. PubMed ID: 22761713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucokinase gene mutations (MODY 2) in Asian Indians.
    Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
    Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation in GCK gene: Beware of SGA child with diabetic mother.
    Tagliaferri F; Grosso C; Balbo M; Bracciolini G; Bertelli E; Secco A; Salina A; Aloi C; Gallo M; Felici E
    Diabetes Res Clin Pract; 2021 Nov; 181():109081. PubMed ID: 34627944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
    Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
    Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of mutations in the glucokinase gene in people clinically characterized as MODY2 without a family history of diabetes.
    Lopez AP; de Dios A; Chiesa I; Perez MS; Frechtel GD
    Diabetes Res Clin Pract; 2016 Aug; 118():38-43. PubMed ID: 27289208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 14-fold increased prevalence of rare glucokinase gene variant carriers in unselected Danish patients with newly diagnosed type 2 diabetes.
    Gjesing AP; Engelbrechtsen L; Cathrine B Thuesen A; Have CT; Hollensted M; Grarup N; Linneberg A; Steen Nielsen J; Christensen LB; Thomsen RW; Johansson KE; Cagiada M; Gersing S; Hartmann-Petersen R; Lindorff-Larsen K; Vaag A; Sørensen HT; Brandslund I; Beck-Nielsen H; Pedersen O; Rungby J; Hansen T
    Diabetes Res Clin Pract; 2022 Dec; 194():110159. PubMed ID: 36400171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
    Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
    Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Identification of a novel glucokinase-E339K mutation in a Chinese maturity onset diabetes of the young 2 pedigree].
    Cai MY; Liang H; Shen YF; Bi Y; Yan JH; Xu F; Weng JP
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):720-3. PubMed ID: 20079205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
    Ding SY; Tribble ND; Kraft CA; Markwardt M; Gloyn AL; Rizzo MA
    Mol Endocrinol; 2010 Jan; 24(1):171-7. PubMed ID: 19934346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare splice site mutation in the gene encoding glucokinase/hexokinase 4 in a patient with MODY type 2.
    Ivanoshchuk DE; Shakhtshneider EV; Ovsyannikova AK; Mikhailova SV; Rymar OD; Oblaukhova VI; Yurchenko AA; Voevoda MI
    Vavilovskii Zhurnal Genet Selektsii; 2020 May; 24(3):299-305. PubMed ID: 33659812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
    Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
    Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing.
    García-Herrero CM; Rubio-Cabezas O; Azriel S; Gutierrez-Nogués A; Aragonés A; Vincent O; Campos-Barros A; Argente J; Navas MA
    PLoS One; 2012; 7(1):e30518. PubMed ID: 22291974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
    Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
    Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.